UNSPSC 51144401: Fipexide

This classification denotes an antidepressant agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) TG44VME01D. European Medicines Agency schedules Fipexide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07630MIG. Fipexide generally arises in the molecular formula C20H21CLN2O4.

UNSPSC 51144401 Fipexide is a Commodity code that encompasses pharmaceutical products and medical supplies procured by state and local health agencies, though the single recent opportunity on record—Seminole County, Florida's IFB for naloxone and drug deactivation systems—shows a mismatch between the code's nominal scope and the actual work being bought. Seminole County issued IFB 60459723LAS in June 2026 to source 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive bidding, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. Vendors were required to submit bids electronically through the county's e-Procurement Portal, include all shipping and delivery costs in their proposals, maintain workers' compensation and commercial general liability insurance, comply with E-Verify requirements, and hold drug-free workplace certification. The contract was structured on a fixed-fee basis with an initial two-year term and one-year renewal option, including a three-month probationary period during which Seminole County could terminate without cause. The procurement was potentially FEMA-funded and subject to federal environmental compliance requirements.

Activity under this Commodity code is limited in the available source records. The single documented recent opportunity originates from a Florida county health department. Beyond this Seminole County solicitation with a July 26, 2023 response date, no additional state or local opportunities under code 51144401 appear in the current record, making geographic spread and issuing-body characterization difficult to establish. The mismatch between the code's fipexide designation and the actual naloxone and drug deactivation systems being procured suggests the code may not be the primary taxonomic home for this work in state and local procurement systems, or that activity under it remains sparse relative to other commodity classifications.